Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Stock Price & Analysis

0 Followers

AAREYDRUGS Stock Chart & Stats

₹108.65₹3.05(2.89%)
At close: 3:30 PM GMT+5:30
₹80₹90₹100₹110Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
INR 105.75 - INR 110.00
52-Week Range
INR 50.31 - INR 118.90
Previous Close
INR 105.60
Volume
N/A
Average Volume (3M)
7,907
Market Cap
INR 2.99B
Enterprise Value
INR 1.91B
Total Cash (Recent Filing)
INR 33.98M
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
74.3
Beta
1.36
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Dec 13, 2018
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Persistent Profitability

The company has remained profitable despite uneven revenue and weaker earnings power. Continued positive net income provides a base for reinvestment and resilience, while demonstrating that the operating model still generates accounting earnings across changing business conditions.

Moderate Leverage

Moderate leverage and a growing equity base provide some balance-sheet support for the business. Although debt has increased, the existing equity cushion may help absorb operating volatility and preserve financial flexibility compared with a more highly leveraged capital structure.

Latest Revenue Rebound

The latest annual revenue increase indicates that the company can regain sales momentum after periods of contraction. A rebound in demand for its pharma products and intermediates could support scale and earnings recovery, provided growth becomes more consistent over time.

Bears Say

Weak Cash Conversion

Repeatedly negative operating and free cash flow shows that reported profits are not consistently converting into internally generated funds. This can constrain reinvestment, increase reliance on external financing, and make the business more vulnerable when operating conditions weaken.

Rising Debt

The sharp increase in debt raises balance-sheet risk, particularly while cash generation remains weak. Higher borrowing can reduce financial flexibility and increase the funding burden, making it harder for the company to support growth or absorb further operating volatility without additional capital.

Thin, Declining Earnings Power

Falling net income over the measured period suggests that profitability has not kept pace with the company’s revenue base. Thin and volatile margins leave less protection against cost or demand pressure, limiting the durability of earnings and reducing capacity to fund expansion internally.

Aarey Drugs & Pharmaceuticals Ltd. News

AAREYDRUGS FAQ

What was Aarey Drugs & Pharmaceuticals Ltd.’s price range in the past 12 months?
Aarey Drugs & Pharmaceuticals Ltd. lowest stock price was ₹50.31 and its highest was ₹118.90 in the past 12 months.
What is Aarey Drugs & Pharmaceuticals Ltd.’s market cap?
Aarey Drugs & Pharmaceuticals Ltd.’s market cap is ₹2.99B.
When is Aarey Drugs & Pharmaceuticals Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aarey Drugs & Pharmaceuticals Ltd.’s earnings last quarter?
Aarey Drugs & Pharmaceuticals Ltd. released its earnings results on Aug 14, 2026. The company reported ₹0.36 earnings per share for the quarter.
Is Aarey Drugs & Pharmaceuticals Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Aarey Drugs & Pharmaceuticals Ltd. pay dividends?
Aarey Drugs & Pharmaceuticals Ltd. pays a Notavailable dividend of ₹0.1 which represents an annual dividend yield of ―. See more information on Aarey Drugs & Pharmaceuticals Ltd. dividends here
What is Aarey Drugs & Pharmaceuticals Ltd.’s EPS estimate?
Aarey Drugs & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aarey Drugs & Pharmaceuticals Ltd. have?
Aarey Drugs & Pharmaceuticals Ltd. has 28,354,303 shares outstanding.
What happened to Aarey Drugs & Pharmaceuticals Ltd.’s price movement after its last earnings report?
Aarey Drugs & Pharmaceuticals Ltd. reported an EPS of ₹0.36 in its last earnings report. Following the earnings report the stock price went down -0.302%.
Which hedge fund is a major shareholder of Aarey Drugs & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:AAREYDRUGS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology